Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Vetbiobank logo — Leading Animal Cell Therapy - Improving Animal Healthcare....

Vetbiobank

Leading Animal Cell Therapy - Improving Animal Healthcare.

Founded 2011 France France 11 employees Venture round Total: $1.46M Biotechnology

General Information

Company Name Vetbiobank
Founded Year 2011
Location France France
Employees 11
Industries Biotechnology
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Vetbiobank. To contact Vetbiobank, visit vetbiobank.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Vetbiobank compare?

A PDF of Vetbiobank and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Vetbiobank soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Vetbiobank

Vetbiobank is a biotech company established in 2011, with its headquarters in France. The company specializes in veterinary regenerative medicine, aiming to improve animal healthcare through the use of neonatal stem cells. Leveraging the expertise of its founder, a former expert in human cell therapy development and cord blood derived stem cells, Vetbiobank focuses on providing veterinarians with high-quality biological products to enhance animal wellbeing. The company received a €1.00M Venture Round investment from Paris Business Angels on 10 October 2019. Vetbiobank's mission is to establish cell therapy products as a primary treatment in veterinary practice, collaborating closely with the veterinary university in Lyon, France, to develop new therapeutic solutions for medical conditions that are currently underserved by existing standards of care. The company's work revolves around harnessing the unique biological potential of stem cells to promote healing and reduce the impact of inflammatory chronic diseases in animals, including dogs, cats, and horses. In summary, Vetbiobank's focus on leveraging advanced biotechnology to develop innovative veterinary regenerative medicine, coupled with its strategic partnerships and recent funding from Paris Business Angels, positions the company as a key player in the ongoing evolution of animal healthcare.

Business keywords: Veterinary Regenerative Medicine, Stem Cell Therapy, Regenerative Veterinary Medicine, Clinical Research, Animal Healthcare, Cellular Therapies, Tissue Products, Medical Conditions, Surgical Solutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €1.00M 1
Paris Business Angels
10 Oct 2019
Grant €71.43K 1
EASME - EU Executive Agency for SMEs
01 Jan 2019
Seed Round €385.00K 1
Health Angels Rhône-Alpes
Health Angels Rhône-Alpes
19 Jul 2013

Vetbiobank Alternatives & Competitors

View All Alternatives
Vetbiobank vs
Vetherapy® - Veterinary Regenerative Medicine
Vetherapy® - Veterinary Regenerative Medicine United States

Vetherapy uses stem cells, PRP, and biomaterials to create effective veterinary regenerative medicin...

Grant
2 employees
Biotechnology
Vetbiobank vs
Celltex Therapeutics Corporation
Celltex Therapeutics Corporation United States

A Houston-based biotech company focused on breakthroughs using autologous, adipose-derived Mesenchym...

Venture round
33 employees
Biotechnology, Health and Wellness
Vetbiobank vs
PrimeCell Bioscience, a.s.
PrimeCell Bioscience, a.s. Czech Republic

Měníme klasické paradigma léčby

4 employees
Biotechnology, Health Care
View all alternatives

FAQ About Vetbiobank

Leading Animal Cell Therapy - Improving Animal Healthcare.
Vetbiobank was founded in 2011.
Vetbiobank is headquartered in France.
Vetbiobank operates in Biotechnology. Its work centres on Veterinary Regenerative Medicine, Stem Cell Therapy, Regenerative Veterinary Medicine and Clinical Research.
Vetbiobank has approximately 11 employees.
Vetbiobank has completed 3 funding rounds, raising a total of $1.46M. The latest funding stage is Venture round.
Top alternatives and competitors to Vetbiobank include Vetherapy® - Veterinary Regenerative Medicine, Celltex Therapeutics Corporation, PrimeCell Bioscience, a.s., BlueRock Therapeutics, InGeneron. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vetbiobank and Vetherapy® - Veterinary Regenerative Medicine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vetbiobank, https://bouncewatch.com/company/vetbiobank, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes